The N-Terminal Transactivation Domain Confers Target Gene Specificity of Hypoxia-inducible Factors HIF-1α and HIF-2α
- 1 November 2007
- journal article
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 18 (11) , 4528-4542
Abstract
The basic helix-loop-helix-Per-ARNT-Sim–proteins hypoxia-inducible factor (HIF)-1α and HIF-2α are the principal regulators of the hypoxic transcriptional response. Although highly related, they can activate distinct target genes. In this study, the protein domain and molecular mechanism important for HIF target gene specificity are determined. We demonstrate that although HIF-2α is unable to activate multiple endogenous HIF-1α–specific target genes (e.g., glycolytic enzymes), HIF-2α still binds to their promoters in vivo and activates reporter genes derived from such targets. In addition, comparative analysis of the N-terminal DNA binding and dimerization domains of HIF-1α and HIF-2α does not reveal any significant differences between the two proteins. Importantly, replacement of the N-terminal transactivation domain (N-TAD) (but not the DNA binding domain, dimerization domain, or C-terminal transactivation domain [C-TAD]) of HIF-2α with the analogous region of HIF-1α is sufficient to convert HIF-2α into a protein with HIF-1α functional specificity. Nevertheless, both the N-TAD and C-TAD are important for optimal HIF transcriptional activity. Additional experiments indicate that the ETS transcription factor ELK is required for HIF-2α to activate specific target genes such as Cited-2, EPO, and PAI-1. These results demonstrate that the HIF-α TADs, particularly the N-TADs, confer HIF target gene specificity, by interacting with additional transcriptional cofactors.Keywords
This publication has 44 references indexed in Scilit:
- Acute postnatal ablation of Hif-2 α results in anemiaProceedings of the National Academy of Sciences, 2007
- The phosphorylation status of PAS‐B distinguishes HIF‐1α from HIF‐2α in NBS1 repressionThe EMBO Journal, 2006
- Role of ETS Transcription Factors in the Hypoxia-Inducible Factor-2 Target Gene SelectionCancer Research, 2006
- Differential Regulation of the Transcriptional Activities of Hypoxia-Inducible Factor 1 Alpha (HIF-1α) and HIF-2α in Stem CellsMolecular and Cellular Biology, 2006
- Contrasting Properties of Hypoxia-Inducible Factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-Associated Renal Cell CarcinomaMolecular and Cellular Biology, 2005
- Inactivation of the Arylhydrocarbon Receptor Nuclear Translocator (Arnt) Suppresses von Hippel-Lindau Disease-Associated Vascular Tumors in MiceMolecular and Cellular Biology, 2005
- Differentiating the functional role of hypoxia‐inducible factor (HIF)‐1α and HIF‐2α (EPAS‐1) by the use of RNA interference: erythropoietin is a HIF‐2α target gene in Hep3B and Kelly cellsThe FASEB Journal, 2004
- A Cross-Talk Between Hypoxia and TGF-β Orchestrates Erythropoietin Gene Regulation Through SP1 and SmadsJournal of Molecular Biology, 2004
- Inhibition of HIF2α Is Sufficient to Suppress pVHL-Defective Tumor GrowthPLOS Biology, 2003
- Transactivation and Inhibitory Domains of Hypoxia-inducible Factor 1αJournal of Biological Chemistry, 1997